Sign In

Key Populations

HIV in Racial and Ethnic Minority Populations

Lesson 6. HIV in Racial and Ethnic Minority Populations

CME/CNE Earn CE credit for this module  PDF Share

Learning Objective Performance Indicators

  • Examine disparities in HIV incidence and prevalence rates among racial/ethnic minority groups in the United States
  • Compare HIV diagnosis rates and care base on race/ethnicity
  • Describe disparities in HIV preexposure prophylaxis (PrEP) coverage among different racial/ethnic groups
  • Identify factors associated with health inequities among racial and ethnic minority populations of persons living with HIV and those at risk for HIV acquisition compared to white populations
  • Summarize strategies for prevention, testing, and care among racial and ethnic minority populations
Last Updated: February 16th, 2024
Author:
David H. Spach, MD
David H. Spach, MD
Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington
Disclosures: None
Reviewer:
Jehan Z. Budak, MD
Jehan Z. Budak, MD
Assistant Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington
Disclosures: None
Table of Contents

Introduction

Background

In the United States, the HIV epidemic disproportionately impacts racial and ethnic minority populations.[1] For all persons with HIV, accessible, affordable, and effective antiretroviral therapy is critical for improving health and preventing transmission of HIV. In the United States, since 2010, national strategies and priorities for HIV have emphasized reducing HIV-related health disparities and inequities, as well as ensuring that all persons with HIV receive access to treatment and care that is nonstigmatizing, culturally sensitive, and culturally competent.[2,3] Unfortunately, disparities and inequities continue to exist.

Multiple factors contribute to HIV-related disparities in the United States, including historical trauma, cultural differences, and socioeconomic inequalities. Clinicians working in the HIV field should be aware of these health disparities because they significantly impact clinical care. It is important to note that the racial disparities in HIV stem from long-standing and ongoing institutionalized racism and other sociostructural barriers, not biological differences. This Topic Review will address the epidemiology of HIV within racial and ethnic minority communities, highlight differences in engagement in care and HIV outcomes, explore key paradigms for understanding unique vulnerabilities to HIV among certain subpopulations, and investigate strategies to reduce HIV-related inequities in racial and ethnic minority populations.

HIV Epidemiology In United States by Race/Ethnicity

HIV Prevalence Estimates Based on Race/Ethnicity

The HIV prevalence is the estimated number of persons living with HIV. This estimate includes persons living with diagnosed or undiagnosed HIV. The Centers for Disease Control and Prevention (CDC) HIV reported that an estimated 1,212,400 persons 13 years of age and older living with HIV (diagnosed and undiagnosed) in the United States at year-end 2021.[4] Of these, 487,500 (40%) were Black/African American individuals, 342,000 (28%) were White people, and 297,200 (25%) were Hispanic/Latino people (Figure 1).[4] Further, Black/African American individuals had the highest HIV prevalence rate (1,402 per 100,000 population at year-end 2021), which was 7 times higher than in White individuals.[4] These data underscore the disproportionate burden of HIV carried by minority populations within the United States, especially Black people.[4,5]

HIV Incidence Estimates Based on Race/Ethnicity

The HIV incidence represents an estimated number of persons who newly acquire HIV during a fixed time period. In the United States, the CDC typically reports estimated HIV incidence as new HIV infections that have occurred over a 1-year period. For the year 2021, the CDC estimated 32,050 persons newly acquired HIV in the United States; among the new HIV infections, 13,000 (41%) occurred in Black/African American individuals, 9,300 (29%) in Hispanic/Latino individuals, 8,200 (26%) in White individuals, and the remaining 5% of new HIV infections occurred in Asian, American Indian/Alaska Native, amid Native Hawaiian/Other Pacific Islander individuals (Figure 2).[4] The estimates for HIV incidence rates (new infections per 100,000 population) showed that Black/African American persons had the highest incidence rates—7.8 times higher than for White persons. In addition, Hispanic/Latino persons had an HIV incidence rate that was approximately 3.9 times higher than the rate in White persons.[4]

Projected Lifetime Risk of Acquiring HIV

The overall projected lifetime risk of being diagnosed with HIV in the United States for all persons is approximately 0.94-0.95% (or 1 in 106 persons); the risk varies significantly by sex and by racial/ethnic group (Figure 3).[6] For males, the lifetime risk of a diagnosis of HIV is 1 in 68, though the risk is much higher among Black/African American men (1 in 22).[6] For females, the lifetime risk of a diagnosis of HIV is 1 in 250, with the highest risk occurring among Black/African American females (1 in 54).[6] These data illustrate the dramatic disparities in HIV acquisition risk that occur among different racial/ethnic groups in the United States.

Comparison of HIV Diagnosis and Care by Race/Ethnicity

The HIV Care Continuum, which is also referred to as the HIV care cascade, represents the framework for providing medical care to persons living with HIV and involves five major steps: (1) diagnosis of HIV, (2) linkage to care, (3) engagement and retention in care, (4) prescription of antiretroviral therapy, and (5) achievement of virologic suppression.[7,8] Some disparities exist along the continuum of HIV care for racial and ethnic minorities, as discussed below.[9,10,11]

HIV Testing and Diagnosis

Screening for HIV and diagnostic testing is a crucial step in the HIV Care Continuum. In the United States in 2021, the proportion of persons living with undiagnosed HIV decreased to less than 21% in all racial/ethnic groups, with a range of 10.4% in multiracial persons to 20.5% in American Indian/Alaska Native individuals(Figure 5).[4] Although the proportion of persons diagnosed with HIV has increased in recent years across racial and ethnic groups, the fraction of those who have been diagnosed in all groups falls short of the national benchmark goal to have at least 90% of persons living with HIV become aware of their HIV serostatus.[2]

Stage at Diagnosis

In 2021, fewer than 26% of persons in all racial/ethnic groups had stage 3 (AIDS) at the time of HIV diagnosis, with the highest rates among Asian individuals and Native Hawaiian/Pacific Islander individuals (Figure 6).[12] Potential barriers to HIV testing in racial/ethnic minority populations include the lack of convenient and culturally/linguistically appropriate testing locations, stigma, poverty, and low perception of HIV risk.[13,14,15,16] 

HIV Care Among People Diagnosed with HIV

The CDC surveillance data reports include rates for receipt of any medical care (indicated by at least one CD4 cell count or HIV RNA measurement during the year) and retention in care (at least 2 CD4 or HIV RNA tests obtained at least 3 months apart during the year).[17] In addition, the CDC surveillance data also includes rates of HIV RNA suppression, which is the final step in the HIV Care Continuum, and it represents a critical outcome measure. In the CDC HIV surveillance report, the rates of viral suppression are based on an HIV RNA level of less than 200 copies/mL on the most recent HIV RNA test during that year.[12] Overall, the year-end 2021 rates of these different HIV care components were relatively similar among different racial/ethnic groups, but were slightly higher in multiracial people and White people; the lowest rates of viral suppression were seen in Black people and Native Hawaiian/Pacific Islander people (Figure 7).[12]

HIV PrEP Coverage by Race/Ethnicity

In 2019, the United States Department of Health and Human Services (HHS) launched the Ending the HIV Epidemic (EHE) initiative with a goal of reducing new HIV infections in the United States by 90% by the year 2030, with the achievement of this goal accomplished through the scale-up of HIV prevention and treatment strategies.[18] The use of HIV preexposure prophylaxis (PrEP) is the central component of the element of the EHE initiative that focuses on preventing HIV infections among persons without HIV who are at risk of acquiring HIV.[18] The Ending the HIV Epidemic goals for 2025 include a goal to increase HIV PrEP coverage to 50%—meaning that 50% of people with an indication for HIV PrEP will have HIV PrEP prescribed for them.[18] In 2022, the HIV PrEP coverage in the United States was 36%, and this represents a significant increase from the 23% HIV PrEP coverage in 2019.[19] The HIV PrEP coverage has varied tremendously based on racial/ethnic groups, with markedly higher coverage in White people at risk for HIV than in Black/African American or Hispanic/Latino people at risk for HIV (Figure 9).[19]

Health Outcomes and Death by Race/Ethnicity

In 2021, based on CDC surveillance data, the number of HIV-related deaths was by far the highest in Black/African American individuals (Figure 8).[20] In addition, the population-based HIV death rate (deaths related to HIV per 100,000 population) was highest among Black/African American persons (20.1), and this death rate was 6.5 times higher than in White persons (3.1).[20] The differences in HIV-related death rates among different ethnic/racial groups are not fully explained by the lower proportion of persons achieving HIV RNA suppression.[21] Retrospective analyses of hospital and insurance records have also found that Black/African American individuals living with HIV are approximately six times more likely than White persons with HIV to require hospitalization.[22] Mortality differences exist across other racial/ethnic groups as well. These differences in health outcomes and deaths highlight major health disparities that continue to occur in Black people with HIV.

Factors Associated with Health Inequities

Several paradigms for understanding the unique vulnerability to HIV in racial and ethnic minority populations have been proposed. This section will explore multiple potential factors that help to explain how significant racial/ethnic inequities have occurred in the HIV epidemic in the United States.

Syndemic Theory

Syndemic refers to two or more factors that interact in a synergistic manner and result in an excess burden of disease that exceeds the contribution of either factor alone.[23] In syndemic theory, social determinants of health are integral to any explanation of high HIV rates in minority communities. Syndemic theory posits that the overlap of HIV, substance use, trauma, poverty, and incarceration are responsible for the disproportionate burden of HIV in minority populations, particularly in persons who are Black/African American or Hispanic/Latino.[23] For example, Black/African American and Hispanic/Latino persons living in poverty are more likely to experiment with injection drug use in adolescence or resort to exchange sex, both of which increase vulnerability to HIV acquisition. Similarly, high rates of drug use and violence lead to higher incarceration rates, which destabilize families and disrupt stable sexual partnerships, further increasing vulnerability to HIV. High sentencing rates for specific drug-related crimes reinforce the syndemic, given the disproportionately large numbers of young Black/African American males who have been incarcerated for drug offenses.[24] The relationships are reciprocal and synergistic, such that incarceration can lead to unemployment and poverty, and poverty can lead to increased drug use and sexual risk-taking, which, in turn, can lead to HIV acquisition.

Risk Environmental Model

The “Risk Environmental Model” proposes that racial and ethnic disparities in HIV infection arise because minority groups more often live in an environment that creates vulnerability to adverse HIV-related outcomes.[25] The “environment” in this model refers to social, economic, political, and physical influences that interact to increase an individual’s vulnerability to HIV.

Minority Stress Theory

The minority stress theory proposes that health disparities among populations can be explained by stressors caused by stigma and discrimination. Extensive social science research has correlated the experiences of stigma and discrimination with adverse health outcomes in relation to cardiovascular disease, mental health, substance use disorders, and HIV infection.[26,27,28,29] Several studies suggest that stressors of stigma and discrimination among minority populations can contribute to increased rates of depression, substance use disorders, and sexual activity that increase the risk of HIV acquisition.[26,30] Ethnic and racial minorities who also experience sexual-orientation-based stigma and discrimination may face a double burden.[31,32] Ethnographic research has identified that stigma and discrimination based on sexual orientation increases HIV acquisition risk behavior similar to the increased risk seen with racial/ethnic-associated stigma and discrimination.[31]

Sexual Networks and Concurrency

Risk for HIV acquisition is mediated not only by traditional sexual-risk factors, such as condomless intercourse, sex with multiple partners, or sex under the influence of alcohol or drugs, but also by sexual networks and patterns of relationships that are integrated into community structures. Concurrent sexual partnerships, defined as sexual relationships that overlap in time, have been identified as a driving factor in the HIV epidemic.[33] Concurrent partnerships may lead to faster spread of HIV than sequential (serial monogamous) partnerships, especially in concurrent situations where both partners are not engaging in monogamy.[33,34] Concurrency may be an especially important factor in HIV transmission for Black/African American women.[33] 

Incarceration

In order to understand the theory that incarceration increases the vulnerability of minority populations to HIV, it is important to recognize the overlapping epidemics of incarceration and HIV, particularly for low-income people of color.[35] In 2021, in the United States, Black/African American persons were imprisoned at a rate 4.8 times higher than in White persons.[36,37] Different rates in drug-related arrests, as well as drug sentencing, are major contributors to the differences in incarceration rates based on race.[24] Similar findings exist among persons with HIV who are incarcerated. In one study that included 1,233 men and women with HIV who entered jail at 10 sites, 65% of subjects self-identified as Black and 25% as Hispanic.[35] Incarceration directly and indirectly contributes to racial and ethnic differences related to HIV acquisition risk. High rates of incarceration among young Black men, for example, lead to fewer young Black men in the community, which causes an imbalanced ratio of men and women in the community.[38] Incarceration also disrupts primary intimate partnerships, and men with incarceration histories have higher rates of multiple sex partners, concurrent partners, unprotected sex, and illicit drug use.[39,40,41] Young people in communities with high rates of violence and incarceration may also suffer from a lack of role models. Adolescents with a history of incarceration have increased rates of activities associated with HIV acquisition, including substance use during sex, condomless sex, and multiple partners.[42,43]

Historical Trauma Theory and Social Victimization

Racial and ethnic segregation, disproportionate incarceration rates in minority communities, and a history of unethical treatment of persons of color have all created mistrust of societal institutions, including the health care system. Examples involving several groups are highlighted below. Efforts to address HIV prevention and treatment in communities that experience historical trauma may fall short unless the factors underlying mistrust and loss are adequately addressed.

  • Black/African American Persons: The Tuskegee experiment is perhaps the most infamous among unethical medical research in the United States. In this study, curative treatment for syphilis was deliberately withheld from 399 Black/African American men so that that the natural history of the disease could be studied.[44] Ongoing experiences of stigma and health care system inequities may contribute to the underutilization of health care services and complicate public health efforts to engage Black/African American individuals in HIV prevention and care.[45,46]
  • Hispanic/Latino Persons: Social marginalization may contribute to the reluctance of Hispanic/Latino populations to seek HIV-related services.[47] One study of 190 sexual and gender minority Hispanic/Latino persons in North Carolina found that avoidance of HIV testing was often due to fear of disclosure and repercussions of a positive test, such as fear the test result would be reported to the government.[48] In addition, reluctance to participate in HIV care may arise among undocumented immigrants who face concerns about deportation.[47]
  • American Indian/Alaska Native Persons: Historical trauma theory can help to explain HIV vulnerabilities among other minority populations. For example, mistrust of the medical establishment, as well as HIV denialism is common among Native populations within the United States.[49,50] One study of Native American persons living on the Fort Peck Reservation in Montana found that a particular type of intergenerational trauma designated as “Historical Loss” (from loss of language, land, and traditional spiritual and cultural identity) is linked to psychological symptoms and an increased likelihood of sex with multiple concurrent partners.[51]

Reducing HIV-related disparities in racial/ethnic minorities will require a coordinated, multidisciplinary approach that addresses the social and structural drivers of HIV (poverty, unemployment, geographic segregation, incarceration, and differential access to health care) and that can be tailored to meet specific local and cultural needs.[52]

Philadelphia’s citywide faith-based HIV prevention campaign, initiated in 2010, provides one example of how a community partnership was successfully created to help achieve national benchmark HIV care continuum goals.[53] The campaign attracted a coalition of faith-based organizations, academic institutions, private and public sector players, and the media in order to promote HIV testing, awareness, and prevention; faith-based organizations played a particularly important role with Black/African American individuals.[53] This campaign demonstrated that community-based advocacy is effective in increasing dialogue around HIV that can translate into public health action.[54]

Patient-provider racial concordance has been shown to improve the rates of testing for sexually transmitted infections among Black/African American women attending sexually transmitted diseases clinics, and both racial and language concordance have been associated with improved rates of medication adherence.[55,56] Early studies also suggested that racial concordance between persons with HIV and their medical providers reduced the time to receipt of antiretroviral therapy.[57] Ongoing efforts for HIV workforce development can play an important role in reducing disparities in HIV medical care. In particular, training more minority clinicians who can provide HIV medical services may help improve engagement in care for minority patients with HIV. Regardless of racial/ethnic concordance or discordance, the level of trust between patient and provider remains paramount, thus reinforcing the need to have a culturally sensitive and competent HIV workforce.[58]

Available evidence suggests that focusing on early engagement in HIV care may yield the greatest returns in terms of improving racial and ethnic disparities in the HIV care cascade. Retention in the first year after HIV diagnosis predicts future patterns of engagement—most individuals who engage in care during the first year remain in care. At the retention step of the HIV Care Continuum, major disparities among racial and ethnic groups emerge.[59] More resources should be directed at ensuring that persons who are diagnosed with HIV are immediately linked to HIV care upon HIV diagnosis and that they receive convenient and culturally sensitive medical care. These efforts should also include strategies and infrastructure to maximize their retention in HIV care.

It is crucial to address the challenges of meeting the health care needs of undocumented immigrants with HIV in the United States. The Affordable Care Act reduced disparities in insurance coverage rates by race and ethnicity but did not extend insurance coverage to undocumented immigrants. Typically, undocumented individuals only qualify for emergency services and pregnancy-related services, which makes it difficult to access medical care for HIV testing, prevention, and treatment.[60] For undocumented individuals, the barrier created by lack of insurance is compounded by others, including lack of knowledge about the health care system, fear of deportation, oppressive work environments, and social isolation.[61] Given the public health implications of excluding an entire subpopulation from access to HIV services, including antiretroviral therapy, it is important that HIV prevention and treatment services are improved for undocumented individuals.

Summary Points

  • In the United States, a disproportionate burden of HIV is carried by Black/African American and Hispanic/Latino populations.
  • Black/African-American persons constitute the highest number and rate of persons with HIV in the United States. Hispanic/Latino persons have the second highest HIV prevalence rate.
  • One of the three main HIV-related federal benchmark goals is to reduce HIV-related health disparities and inequities.
  • The percentage of persons with undiagnosed HIV is less than 13% in White, Asian, and Black/African American individuals.
  • Along the HIV Care Continuum, Black/African American persons have relatively lower rates of linkage to HIV medical care, retention in care, and virologic suppression.
  • Major disparities exist in HIV PrEP coverage with Black/African American and Hispanic/Latino individuals having much lower HIV PrEP coverage than White individuals. 
  • The number and rate of deaths in persons with HIV in the United States was by far the highest in Black/African American individuals at year-end 2021. 
  • Several paradigms for understanding the unique vulnerability to HIV in racial and ethnic minority populations have been proposed, including syndemic theory, the risk environmental model, minority stress theory, historical trauma theory, and other paradigms that emphasize the impact of sexual networks and incarceration on HIV risk.
  • Reducing disparities in HIV infection and improving outcomes in racial and ethnic minorities will require a coordinated, multidisciplinary approach.
  • HIV workforce development efforts should include the recruitment of more minority healthcare providers as well as on improving cultural competency.
  PDF Share

Citations

  1. 1.Song R, Hall HI, Green TA, Szwarcwald CL, Pantazis N. Using CD4 Data to Estimate HIV Incidence, Prevalence, and Percent of Undiagnosed Infections in the United States. J Acquir Immune Defic Syndr. 2017;74:3-9.
  2. 2.White House Office of National AIDS Policy. National HIV/AIDS Strategy for the United States: Updated to 2020. Washington, DC. July 2015.
  3. 3.White House Office of National AIDS Policy. The National HIV/AIDS Strategy for the United States. July 2010.
  4. 4.Centers for Disease Control and Prevention. Estimated HIV Incidence and Prevalence in the United States, 2017–2021. HIV Surveillance Supplemental Report. 2023;28(3). Published May 2023.
    [CDC] -
  5. 5.U.S. Census Bureau. Population Estimates.
  6. 6.Hess KL, Hu X, Lansky A, Mermin J, Hall HI. Lifetime risk of a diagnosis of HIV infection in the United States. Ann Epidemiol. 2017;27:238-243.
  7. 7.Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52:793-800.
  8. 8.Cheever LW. Engaging HIV-infected patients in care: their lives depend on it. Clin Infect Dis. 2007;44:1500-2.
  9. 9.Whiteside YO, Cohen SM, Bradley H, Skarbinski J, Hall HI, Lansky A. Progress along the continuum of HIV care among blacks with diagnosed HIV- United States, 2010. MMWR Morb Mortal Wkly Rep. 2014;63:85-9.
  10. 10.Hall HI, Frazier EL, Rhodes P, et al. Differences in human immunodeficiency virus care and treatment among subpopulations in the United States. JAMA Intern Med. 2013;173:1337-44.
  11. 11.Gant Z, Bradley H, Hu X, Skarbinski J, Hall HI, Lansky A. Hispanics or Latinos living with diagnosed HIV: progress along the continuum of HIV care - United States, 2010. MMWR Morb Mortal Wkly Rep. 2014;63:886-90.
  12. 12.Centers for Disease Control and Prevention. Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data—United States and 6 Dependent Areas, 2021. HIV Surveillance Supplemental Report. 2023;28(No. 4). Published May 2023.
    [CDC] -
  13. 13.Rios-Ellis B, Becker D, Espinoza L, et al. Evaluation of a Community Health Worker Intervention to Reduce HIV/AIDS Stigma and Increase HIV Testing Among Underserved Latinos in the Southwestern U.S. Public Health Rep. 2015;130:458-67.
  14. 14.Washington TA, D'Anna L, Meyer-Adams N, Malotte CK. From Their Voices: Barriers to HIV Testing among Black Men Who Have Sex with Men Remain. Healthcare (Basel). 2015;3:933-947.
  15. 15.Hahm HC, Song IH, Ozonoff A, Sassani JC. HIV testing among sexually experienced Asian and Pacific Islander young women association with routine gynecologic care. Womens Health Issues. 2009;19:279-88.
  16. 16.Lopez-Quintero C, Rojas P, Dillon FR, Varga LM, De La Rosa M. HIV testing practices among Latina women at risk of getting infected: a five-year follow-up of a community sample in South Florida. AIDS Care. 2016;28:137-46.
  17. 17.Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 U.S. dependent areas, 2017. HIV Surveillance Supplemental Report. 2019;24(No. 3):1-74. Published June 2019.
    [CDC] -
  18. 18.Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV Epidemic: A Plan for the United States. JAMA. 2019;321:844-845.
  19. 19.Centers for Disease Control and Prevention. Core indicators for monitoring the Ending the HIV Epidemic initiative (preliminary data): National HIV Surveillance System data reported through March 2023; and preexposure prophylaxis (PrEP) data reported through December 2022. HIV Surveillance Data Tables 2023;4(2). Published June 2023.
    [CDC] -
  20. 20.Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2021. HIV Surveillance Report, 2021; vol. 34. Published May 2023.
    [CDC] -
  21. 21.Pettersen PS, Brox IK, Naman E, et al. Antiretroviral treatment failure predicts mortality in rural Tanzania. Int J STD AIDS. 2015;26:633-9.
  22. 22.Oramasionwu CU, Hunter JM, Skinner J, et al. Black race as a predictor of poor health outcomes among a national cohort of HIV/AIDS patients admitted to US hospitals: a cohort study. BMC Infect Dis. 2009;9:127.
  23. 23.Wilson PA, Nanin J, Amesty S, Wallace S, Cherenack EM, Fullilove R. Using syndemic theory to understand vulnerability to HIV infection among Black and Latino men in New York City. J Urban Health. 2014;91:983-98.
  24. 24.National Association for the Advancement of Colored People (NAACP). Criminal Justice Fact Sheet.
    [NAACP] -
  25. 25.Cooper HL, Linton S, Kelley ME, et al. Racialized risk environments in a large sample of people who inject drugs in the United States. Int J Drug Policy. 2016;27:43-55.
  26. 26.Bowleg L, Fitz CC, Burkholder GJ, et al. Racial discrimination and posttraumatic stress symptoms as pathways to sexual HIV risk behaviors among urban Black heterosexual men. AIDS Care. 2014;26:1050-7.
  27. 27.Everson-Rose SA, Lutsey PL, Roetker NS, et al. Perceived Discrimination and Incident Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol. 2015;182:225-34.
  28. 28.Hatzenbuehler ML, Phelan JC, Link BG. Stigma as a fundamental cause of population health inequalities. Am J Public Health. 2013;103:813-21.
  29. 29.Williams DR, Neighbors HW, Jackson JS. Racial/ethnic discrimination and health: findings from community studies. Am J Public Health. 2008;98:S29-37.
  30. 30.Magnus M, Kuo I, Shelley K, et al. Risk factors driving the emergence of a generalized heterosexual HIV epidemic in Washington, District of Columbia networks at risk. AIDS. 2009;23:1277-84.
  31. 31.Frye V, Nandi V, Egan J, et al. Sexual orientation- and race-based discrimination and sexual HIV risk behavior among urban MSM. AIDS Behav. 2015;19:257-69.
  32. 32.Han CS, Ayala G, Paul JP, Boylan R, Gregorich SE, Choi KH. Stress and coping with racism and their role in sexual risk for HIV among African American, Asian/Pacific Islander, and Latino men who have sex with men. Arch Sex Behav. 2015;44:411-20.
  33. 33.Adimora AA, Schoenbach VJ, Taylor EM, Khan MR, Schwartz RJ. Concurrent partnerships, nonmonogamous partners, and substance use among women in the United States. Am J Public Health. 2011;101:128-36.
  34. 34.Morris M, Kretzschmar M. Concurrent partnerships and the spread of HIV. AIDS. 1997;11:641-8.
  35. 35.Stein MS, Spaulding AC, Cunningham M, et al. HIV-positive and in jail: race, risk factors, and prior access to care. AIDS Behav. 2013;17 Suppl 2:S108-17.
  36. 36.Carson EA, Klucklow R. Correctional Populations in the United States, 2021 – Statistical Tables. Bureau of Justice Statistics: Office of Justice Programs, U.S. Department of Justice. February, 2023.
  37. 37.Nellis A. The Color of Justice: Racial and Ethnic Disparity in State Prisons. The Sentencing Project. October 13, 2021
  38. 38.Pouget ER, Kershaw TS, Niccolai LM, Ickovics JR, Blankenship KM. Associations of sex ratios and male incarceration rates with multiple opposite-sex partners: potential social determinants of HIV/STI transmission. Public Health Rep. 2010;125 Suppl 4:70-80.
  39. 39.Khan MR, Behrend L, Adimora AA, Weir SS, White BL, Wohl DA. Dissolution of primary intimate relationships during incarceration and implications for post-release HIV transmission. J Urban Health. 2011;88:365-75.
  40. 40.Khan MR, Doherty IA, Schoenbach VJ, Taylor EM, Epperson MW, Adimora AA. Incarceration and high-risk sex partnerships among men in the United States. J Urban Health. 2009;86:584-601.
  41. 41.Widman L, Noar SM, Golin CE, Willoughby JF, Crosby R. Incarceration and unstable housing interact to predict sexual risk behaviours among African American STD clinic patients. Int J STD AIDS. 2014;25:348-54.
  42. 42.Hurd NM, Valerio MA, Garcia NM, Scott AA. Adapting an HIV prevention intervention for high-risk, incarcerated adolescents. Health Educ Behav. 2010;37:37-50.
  43. 43.Hurd NM, Zimmerman MA, Xue Y. Negative adult influences and the protective effects of role models: a study with urban adolescents. J Youth Adolesc. 2009;38:777-89.
  44. 44.Gamble VN. Under the shadow of Tuskegee: African Americans and health care. Am J Public Health. 1997;87:1773-8.
  45. 45.Brandon DT, Isaac LA, LaVeist TA. The legacy of Tuskegee and trust in medical care: is Tuskegee responsible for race differences in mistrust of medical care? J Natl Med Assoc. 2005;97:951-6.
  46. 46.Scharff DP, Mathews KJ, Jackson P, Hoffsuemmer J, Martin E, Edwards D. More than Tuskegee: understanding mistrust about research participation. J Health Care Poor Underserved. 2010;21:879-97.
  47. 47.Levison JH, Levinson JK, Alegría M. A Critical Review and Commentary on the Challenges in Engaging HIV-Infected Latinos in the Continuum of HIV Care. AIDS Behav. 2018;22:2500-2512.
  48. 48.Gilbert PA, Rhodes SD. HIV testing among immigrant sexual and gender minority Latinos in a US region with little historical Latino presence. AIDS Patient Care STDS. 2013;27:628-36.
  49. 49.Gilley BJ, Keesee M. Linking 'White oppression' and HIV/AIDS in American Indian etiology: conspiracy beliefs among MSMs and their peers. Am Indian Alsk Native Ment Health Res. 2007;14:44-62.
  50. 50.Negin J, Aspin C, Gadsden T, Reading C. HIV Among Indigenous peoples: A Review of the Literature on HIV-Related Behaviour Since the Beginning of the Epidemic. AIDS Behav. 2015;19:1720-34.
  51. 51.Anastario MP, FourStar K, Rink E. Sexual risk behavior and symptoms of historical loss in American Indian men. J Community Health. 2013;38:894-9.
  52. 52.Aral SO, Adimora AA, Fenton KA. Understanding and responding to disparities in HIV and other sexually transmitted infections in African Americans. Lancet. 2008;372:337-40.
  53. 53.Nunn A, Cornwall A, Thomas G, et al. What's God got to do with it? Engaging African-American faith-based institutions in HIV prevention. Glob Public Health. 2013;8:258-69.
  54. 54.Nunn A, Sanders J, Carson L, et al. African American community leaders' policy recommendations for reducing racial disparities in HIV infection, treatment, and care: results from a community-based participatory research project in Philadelphia, Pennsylvania. Health Promot Pract. 2015;16:91-100.
  55. 55.Ford CL, Konrad TR, Godette DC, Corbie-Smith G. Acceptance of routine ELISA testing among black women STD patients: relationship to patient-provider racial concordance. Sex Transm Dis. 2008;35:211-3.
  56. 56.Traylor AH, Schmittdiel JA, Uratsu CS, Mangione CM, Subramanian U. Adherence to cardiovascular disease medications: does patient-provider race/ethnicity and language concordance matter? J Gen Intern Med. 2010;25:1172-7.
  57. 57.King WD, Wong MD, Shapiro MF, Landon BE, Cunningham WE. Does racial concordance between HIV-positive patients and their physicians affect the time to receipt of protease inhibitors? J Gen Intern Med. 2004;19:1146-53.
  58. 58.Sohler NL, Wong MD, Cunningham WE, Cabral H, Drainoni ML, Cunningham CO. Type and pattern of illicit drug use and access to health care services for HIV-infected people. AIDS Patient Care STDS. 2007;21 Suppl 1:S68-76.
  59. 59.Dasgupta S, Oster AM, Li J, Hall HI. Disparities in Consistent Retention in HIV Care - 11 States and the District of Columbia, 2011-2013. MMWR Morb Mortal Wkly Rep. 2016;65:77-82.
  60. 60.Clemans-Cope L, Kenney GM, Buettgens M, Carroll C, Blavin F. The Affordable Care Act's coverage expansions will reduce differences in uninsurance rates by race and ethnicity. Health Aff (Millwood). 2012;31:920-30.
  61. 61.Tanser F, Bärnighausen T, Vandormael A, Dobra A. HIV treatment cascade in migrants and mobile populations. Curr Opin HIV AIDS. 2015;10:430-8.

Additional References

  • Bogart LM, Mutchler MG, McDavitt B, et al. A Randomized Controlled Trial of Rise, a Community-Based Culturally Congruent Adherence Intervention for Black Americans Living with HIV. Ann Behav Med. 2017;51:868-878.
  • Brownley JR, Fallot RD, Wolfson Berley R, Himelhoch SS. Trauma history in African-American women living with HIV: effects on psychiatric symptom severity and religious coping. AIDS Care. 2015;27:964-71.
  • Centers for Disease Control and Prevention. Estimated HIV Incidence and Prevalence in the United States, 2014–2018. HIV Surveillance Supplemental Report. 2020;25(No. 1):1-77. Published May 2020.
    [CDC] -
  • Dennis AM, Napravnik S, Seña AC, Eron JJ. Late entry to HIV care among Latinos compared with non-Latinos in a southeastern US cohort. Clin Infect Dis. 2011;53:480-7.
  • Freeman R, Gwadz MV, Silverman E, et al. Critical race theory as a tool for understanding poor engagement along the HIV care continuum among African American/Black and Hispanic persons living with HIV in the United States: a qualitative exploration. Int J Equity Health. 2017;16:54.
  • Mays VM, Coles CN, Cochran SD. Is there a legacy of the U.S. Public Health Syphilis Study at Tuskegee in HIV/AIDS-related beliefs among heterosexual African-Americans and Latinos? Ethics Behav. 2012;22:461-471.
  • Pellowski JA, Price DM, Allen AM, Eaton LA, Kalichman SC. The differences between medical trust and mistrust and their respective influences on medication beliefs and ART adherence among African-Americans living with HIV. Psychol Health. 2017;32:1127-1139.
  • Rosenberg ES, Millett GA, Sullivan PS, Del Rio C, Curran JW. Understanding the HIV disparities between black and white men who have sex with men in the USA using the HIV care continuum: a modeling study. Lancet HIV. 2014;1:e112-e118.
  • Sheehan DM, Trepka MJ, Dillon FR. Latinos in the United States on the HIV/AIDS care continuum by birth country/region: a systematic review of the literature. Int J STD AIDS. 2015;26:1-12.

Figures

These estimates are for persons aged 13 years and older living with diagnosed and undiagnosed HIV infection in the United States at year-end 2021.
Figure 1. Estimated HIV Prevalence, by Race/Ethnicity, United States, 2021
These estimates are for persons aged 13 years and older living with diagnosed and undiagnosed HIV infection in the United States at year-end 2021.
Source: Centers for Disease Control and Prevention. Estimated HIV Incidence and Prevalence in the United States, 2017–2021. HIV Surveillance Supplemental Report. 2023;28(3). Published May 2023.
These estimates are for persons aged 13 years and older in the United States who newly acquired HIV during 2021.
Figure 2. Estimated New HIV Infections, by Race/Ethnicity, United States, 2021
These estimates are for persons aged 13 years and older in the United States who newly acquired HIV during 2021.
Source: Centers for Disease Control and Prevention. Estimated HIV Incidence and Prevalence in the United States, 2017–2021. HIV Surveillance Supplemental Report. 2023;28(3). Published May 2023.
The numbers shown in this table represent the probability as "one in n" persons who will be diagnosed with HIV during their lifetime.
Figure 3. Lifetime Risk of HIV Diagnosis in Males and Females, by Race/Ethnicity
The numbers shown in this table represent the probability as "one in n" persons who will be diagnosed with HIV during their lifetime.
Source: Hess KL, Hu X, Lansky A, Mermin J, Hall HI. Lifetime risk of a diagnosis of HIV infection in the United States. Ann Epidemiol. 2017;27:238-43.
Figure 4. Estimated HIV Incidence for Hispanic/Latino Persons, United States, 2014-2018
Source: Centers for Disease Control and Prevention. Estimated HIV Incidence and Prevalence in the United States, 2014–2018. HIV Surveillance Supplemental Report. 2020;25(No. 1):1-77. Published May 2020.
Figure 5. Persons with Undiagnosed HIV, by Race/Ethnicity, United States, 2021
Source: Centers for Disease Control and Prevention. Estimated HIV Incidence and Prevalence in the United States, 2017–2021. HIV Surveillance Supplemental Report. 2023;28(3). Published May 2023.
These data are from 47 states and the District of Columbia.
Figure 6. Stage 3 (AIDS) at Time of HIV Diagnosis, by Race/Ethnicity, United States, 2021
These data are from 47 states and the District of Columbia.
Source: Centers for Disease Control and Prevention. Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data—United States and 6 Dependent Areas, 2021. HIV Surveillance Supplemental Report. 2023;28(No. 4). Published May 2023.
These data are from 47 states and the District of Columbia.
Figure 7. HIV Care Among People with Diagnosed HIV, United States, 2021
These data are from 47 states and the District of Columbia.
Source: Centers for Disease Control and Prevention. Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data—United States and 6 Dependent Areas, 2021. HIV Surveillance Supplemental Report. 2023;28(No. 4). Published May 2023.
Figure 8. Deaths of Persons with Diagnosed HIV, by Race/Ethnicity, United States, 2021
Source: Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2021. HIV Surveillance Report, 2021; vol. 34. Published May 2023.
Figure 9. HIV PrEP Coverage, by Racial/Ethnic Group, United States, through December 2022
Source: Centers for Disease Control and Prevention. Core indicators for monitoring the Ending the HIV Epidemic initiative (preliminary data): National HIV Surveillance System data reported through March 2023; and preexposure prophylaxis (PrEP) data reported through December 2022. HIV Surveillance Data Tables 2023;4(2). Published June 2023.
  PDF Share

Share by e-mail

Check
-On-
Learning
Questions
The Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.

You must be signed in to customize your interaction with these questions.

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.